Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis

NCT03483012 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Atezolizumab
PROCEDURE: Stereotactic radiosurgery (SRS)

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]